Post Traumatic Stress Disorder
Conditions
Keywords
PTSD, Brief SEE FAR CBT, Intervention
Brief summary
This clinical intervention study evaluates a newly developed Brief SEE FAR CBT protocol for adults aged 18 years and older with posttraumatic stress disorder (PTSD), compared with dynamic psychotherapy treatment as usual. Participants in the Brief SEE FAR CBT group will receive 6 focused sessions emphasizing intrusive PTSD symptoms and will then continue to complete the full 12-session SEE FAR CBT protocol. Participants in the control group will receive dynamic psychotherapy as treatment as usual. Psychological outcomes will be assessed using self-report questionnaires at four time points: baseline, after 6 sessions, after 12 sessions, and at a 3-month follow-up. The study aims to examine changes in PTSD symptoms, anxiety, depression, perceived stress, resilience, somatic symptoms, sleep quality, and related psychological outcomes over the course of treatment and follow-up.
Interventions
BEHAVIORALBrief SEE FAR CBT Intervention
Brief SEE FAR CBT is a focused trauma-oriented cognitive-behavioral intervention based on the SEE FAR CBT approach. The brief protocol consists of 6 sessions delivered approximately once weekly, with emphasis on intrusive PTSD symptoms. Participants will then continue treatment to complete the full 12-session SEE FAR CBT protocol.
BEHAVIORALDynamic Psychotherapy Treatment as Usual
Participants will receive dynamic psychotherapy as treatment as usual, delivered approximately once weekly. This comparison condition represents the standard psychological treatment provided to participants in this clinical setting.
Sponsors
Community Stress Prevention Center
Tel Hai College
The Center for Psychological Services Sha'ar Hanegev
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Participants will be assigned to one of two parallel groups. One group will receive the Brief SEE FAR CBT protocol followed by completion of the full 12-session SEE FAR CBT protocol. The comparison group will receive dynamic psychotherapy as treatment as usual.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participants must meet all of the following criteria: * Age 18 years or older * PTSD symptoms, defined as a PCL-5 score of 30-60 * Hebrew-speaking * Able to provide informed consent * Willing and able to participate in the assigned psychological intervention and complete study questionnaires at baseline, after 6 sessions, after 12 sessions, and at 3-month follow-up
Exclusion criteria
Participants will be excluded if they meet any of the following criteria: * Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes * Currently receiving psychotherapy of any type that began less than 3 months prior to enrollment * Initiation of psychiatric medication less than 3 months prior to enrollment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in PTSD symptoms | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | PTSD Checklist for DSM-5 (PCL-5) PTSD symptoms will be assessed using the PCL-5. Total scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity. Change in PCL-5 total score will be examined from baseline to after 6 sessions, from baseline to after 12 sessions, from baseline to 3-month follow-up, from after 6 sessions to after 12 sessions, and from after 12 sessions to 3-month follow-up. |
| Change in anxiety symptoms | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | Generalized Anxiety Disorder-7 (GAD-7) Anxiety symptoms will be assessed using the GAD-7. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Change in GAD-7 total score will be examined from baseline to after 6 sessions, from baseline to after 12 sessions, from baseline to 3-month follow-up, from after 6 sessions to after 12 sessions, and from after 12 sessions to 3-month follow-up. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in depressive symptoms | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | Patient Health Questionnaire-9 (PHQ-9) Depressive symptoms will be assessed using the PHQ-9. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. Change in PHQ-9 total score will be examined across the four study assessment points. |
| Change in perceived stress | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | Perceived Stress Scale (PSS) Perceived stress will be assessed using the PSS. Total scores range from 0 to 40, with higher scores indicating greater perceived stress. Change in PSS total score will be examined across the four study assessment points. |
| Change in resilience | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | Connor-Davidson Resilience Scale (CD-RISC) esilience will be assessed using the CD-RISC. Total scores range from 0 to 40, with higher scores indicating greater resilience. Change in CD-RISC total score will be examined across the four study assessment points. |
| Change in somatic symptoms | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | Patient Health Questionnaire-15 (PHQ-15) Somatic symptoms will be assessed using the PHQ-15. Total scores range from 0 to 30, with higher scores indicating greater somatic symptom severity. Change in PHQ-15 total score will be examined across the four study assessment points. |
| Change in trauma-related use of imagination and coping | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | FRAME Trauma-related use of imagination and coping will be assessed using the FRAME questionnaire. The FRAME is a 21-item measure of fantastic reality ability, defined as the capacity to use imagination in response to stress or trauma. Items are rated on a 1-7 Likert scale, and mean scores range from 1 to 7, with higher scores indicating greater fantastic reality ability. Change in FRAME score will be examined across the four study assessment points. |
| Change in sleep quality | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | Brief Version of the Pittsburgh Sleep Quality Index Sleep quality will be assessed using the brief version of the Pittsburgh Sleep Quality Index. Change in sleep quality score will be examined across the four study assessment points. |
| Change in PTSD-related functional impairment | Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention | PTSD-related functional impairment will be assessed using the functional impairment section of the Posttraumatic Diagnostic Scale (PDS). This section includes 7 items assessing the extent to which PTSD-related problems interfered with work, relationships, leisure activities, family relationships, sex life, general life satisfaction, and overall functioning during the past two weeks. Items are rated from 0 to 4, and total scores range from 0 to 28, with higher scores indicating greater functional impairment. Change in functional impairment score will be examined across the four study assessment points. |
Countries
Israel
Contacts
CONTACTMeital Mashash, PhD
CONTACTSivan Raz, PhD
PRINCIPAL_INVESTIGATORMeital Mashash, PhD
Community Stress Prevention Center
PRINCIPAL_INVESTIGATORSivan Raz, PhD
Tel Hai College
Outcome results
None listed